{"name":"Inhibikase Therapeutics","slug":"inhibikase-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":29793146,"netIncome":-48259189,"cash":181204516,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2024"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPUjB4Qm4yaDBaWjdmMVphc1ZSOVJlVG5xUUZEMk5ndU1Oc2cxV3g2LWtIYmhvRFRkMUlYYnp0ekRrcmFTMmVmemN2SjlyeG1IWm9FeEpLcXBxZzIyNkJIY0VYbXktdWpXMjQ4aEJiRGYwVk5hNFZiWkcydDB2eTFWOXdsWXpMUFNFTk1yQmE0WXpyTjhaQ25KRkJ3dDVHdVdCUC1NOUVXbm9JZmNUZmN6bjF6X3F2Y2x4WWFUeXl3a3FTZ1hreF9HM2FlbWJjMmtTY2dKaERMci1BVE5TbDFtU3BQNU5iYzVodzhIeVBQeURyRGtlYzBiMUZLNklPS1R6TmFYekRWWXhyT3NiS05PeWRmTHFUWEthQmtmc3UwczFZaWZoXzNUVjdNVjROcTRKUEtPNmNzQVhkZjB6SHR4Vk5uM3lKN1NwNzBhRGxPOW80Zw?oc=5","date":"2026-04-07","type":"pipeline","source":"GlobeNewswire","summary":"Inhibikase Therapeutics Announces Enrollment of First - GlobeNewswire","headline":"Inhibikase Therapeutics Announces Enrollment of First","sentiment":"neutral"},{"date":"2026-04-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOTjFRZlMya0RhRG1uSGdHN2RkZXdpNTRGSWtXeW44MmZIWlJMQkVIR25PcDZqVlpGbV9GN2pkN3VCNTgyX00tcGc5dzFDN3RncmJuc09GQkg2eG5RRjVva0gwejRscEg3WTdTTUQyZGNNZEUycU1fbDlNVjZiaGhtcnhmZG5XcUd6a0NLSE93YmpsZnpIS0lzalFzNlVfb2pDbkpaaVRhTk5zRG00VF9STzAtTHE?oc=5","date":"2026-04-03","type":"pipeline","source":"National Today","summary":"Inhibikase Therapeutics Announces Inducement Grants - National Today","headline":"Inhibikase Therapeutics Announces Inducement Grants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxONFBzQlF6cVVhMlFWRTJwN3FFNk1ZUDh4LURBY1JKSEp0VVlMV29JN3JLYlNjV2FCYmNJUUQzOTAzNFBleWM4czAxWjczcE9nN0QzRDQ4Qmo4YVZVV09RM3pldDVfS1AwSUNHRE0yRkhfTXF2S2ROOWhaVXhDVWxhNlVrQWVHLWc3V1N3YUpUX0o4a2Y5Z3VwcG44dXUtbUVfS3lPWE1DaGQ5bExJOWNIV3A0TFAyYlkwaUpVVElZUG9ZYXhTVHpsX0pTNHlYeko2cDhxWktmS2RyaVNsY3lxc1F0WDF3RDdWTEE1aXRmTjFkZ3pRSlZqa20xRDdnUQ?oc=5","date":"2026-03-26","type":"pipeline","source":"GlobeNewswire","summary":"Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity - GlobeNewswire","headline":"Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity","sentiment":"neutral"},{"date":"2026-03-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPVzFMRFdjS3JQNnV4b1F4MFUyMVZTZmhWaldtNHFlLVJqaWVJYlByLWpaZHQxN1RwdDZySVpkdE5JbWJxRVVDTTZCR0xrb0VlM3Q5YmU2eE9jVnBmMUVJa0JER3BSdEZ3QzRlR0NiQ21hUXFvM1A3RlRwZnJwdkl1bUdkWVZzcGRHdmpRLW9UUkgzaElhZzBDa3FfOGJvV1hWVW5LbDRkQVNQQ3J5a0VRcjRXSFRMV2U2NTRIZjVxNmFzS1UxYzlfQWxBejZaSVJFUXQzV01oUlYyWldDeUpFck9mNnRWTjBCWDcxbnVubEo3SFhLeWc?oc=5","date":"2026-02-24","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on These Healthcare Stocks: Vanda (VNDA), Abeona Therapeutics (ABEO) - The Globe and Mail","headline":"Analysts Are Bullish on These Healthcare Stocks: Vanda (VNDA), Abeona Therapeutics (ABEO)","sentiment":"neutral"},{"date":"2025-12-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-16","type":"pipeline","source":"simplywall.st","summary":"While institutions invested in Inhibikase Therapeutics, Inc. (NASDAQ:IKT) benefited from last week's 11% gain, individual investors stood to gain the most - simplywall.st","headline":"While institutions invested in Inhibikase Therapeutics, Inc. (NASDAQ:IKT) benefited from last week's 11% gain, individua","sentiment":"neutral"},{"date":"2025-11-21","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxPREtlVjVWVUp0cjZFWVQ2MU9wbjVSRmlIc29GWEMyLXhfVkpOeUc2cHFNYVc5OThvYmVMdjZaTlBYbEZCX2VDV2p0SGpvWHNJcXRHY0JWeXpYbDc2VFhZMHFldkJHbW9kcFBQWXNMemQ2aXg5bi1nSzhBY24tek8zVjlZVmZXRUJJMU1xbi1EX3REQWNRN2M2Y0pqUENVV0ZqV0h6Tkx0c3dnM3JjY2dQMFJ3T3hRRHFlZGJ5RWlqdURrOXl5b3h4TzhGOU55ZFRIUnFpTTRlMEl2S1ctajl1VEhjQ0dCOXVMcnNBcDg3aXpzMEk2LTE1Nk9JcHRGZkJuOEE?oc=5","date":"2025-11-20","type":"trial","source":"GlobeNewswire","summary":"Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension - GlobeNewswire","headline":"Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPSDVzSm1wOU15WmVaTFJUbkoxbHhVTEJoQmJmZHNXNEkzUnRCM2N3R0tZOWZFXzEzZWxLZE92SUNCSk0xTmNvaHhxaV9SVEREVTcwUHlDYjk5bXJXSm93bHpTYklfb1JQTFdFVTFTdjBNYU9RNzNPT25YS0ZKTGRXZU5zck5oZXcyZWdnaGY4NmlfMnZIZmwtdFNqSjZvOUpFLUkwVmg4a3M?oc=5","date":"2025-08-19","type":"pipeline","source":"Fierce Pharma","summary":"Inhibikase taps commercial chief from Pfizer, Gilead to pave the way for PAH launch - Fierce Pharma","headline":"Inhibikase taps commercial chief from Pfizer, Gilead to pave the way for PAH launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNOHhZTmFyblpuM3c1OFVTYzA1R28tdHNidE1XWHo5aWRuM3FtZC1zQlNCZlYzdnJGRFptSmRwdTVBYVk0U2dGeXFwTG5vRGhNci1QOXJLMzhpcmhLY3JPd1NGdEZWWW1hakZtSFc3YjBSVDdRWml2WU1ZNnZRcFg3VlBHdjR1SXNDcE5fdQ?oc=5","date":"2025-05-16","type":"pipeline","source":"Fierce Biotech","summary":"BMS oncology head swings to Syndax—Chutes & Ladders - Fierce Biotech","headline":"BMS oncology head swings to Syndax—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONHF0MzhvczZRdFNUcUdKNnBvV1hJQTk2SEx3UkNfY2xreTdXVEZjM1VkOXhQa25PYm1IZWV0YXYzWUVkNktoQU9JT0dSMkZ2YmxlTlUyb2x4SlF6cTJRNjFSTF9ob1lsa2g4Nm5wMi1HdjRWazRFX2p6dDVwanNyaXprQ3haMDNTeW85aEdCQ1BKTkhuRHd0aEJtMFJzNE01b0xiRmNsaFVkaS1mWXBKS3Bzdy1RMmlhOU5VNER3SFNqUkU?oc=5","date":"2025-05-12","type":"pipeline","source":"Fierce Biotech","summary":"Former Inhibikase leader launches new biotech for midstage Parkinson's asset - Fierce Biotech","headline":"Former Inhibikase leader launches new biotech for midstage Parkinson's asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE5WaUU5dTQ0R0JaZEY2X3R5LXBQNnRIQmpUeVB0NGFacXQwYXBLWktGam45UnMxTzNuSk9tT251SExGMTQxaFVzTnUtMFQ4OXR2TUE?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"IKT Stock Price, News & Analysis - Stock Titan","headline":"IKT Stock Price, News & Analysis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2024-12-31","revenueHistory":[{"value":0,"period":"2024-12-31"},{"value":260501,"period":"2023-12-31"},{"value":260501,"period":"2023-12-31"},{"value":123440,"period":"2022-12-31"},{"value":123440,"period":"2022-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":29793146,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-48259189,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":181204516,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}